Ryan Specialty Holdings, Inc. (NYSE:RYAN) Holdings Lifted by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc grew its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 160.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 105,490 shares of the company’s stock after purchasing an additional 65,014 shares during the period. Ensign Peak Advisors Inc’s holdings in Ryan Specialty were worth $6,768,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Barclays PLC grew its position in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Embree Financial Group boosted its holdings in shares of Ryan Specialty by 64.1% in the fourth quarter. Embree Financial Group now owns 83,212 shares of the company’s stock valued at $5,339,000 after acquiring an additional 32,500 shares in the last quarter. KBC Group NV boosted its holdings in shares of Ryan Specialty by 1,803.6% in the fourth quarter. KBC Group NV now owns 46,181 shares of the company’s stock valued at $2,963,000 after acquiring an additional 43,755 shares in the last quarter. Mutual of America Capital Management LLC boosted its holdings in shares of Ryan Specialty by 1.7% in the fourth quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company’s stock valued at $3,606,000 after acquiring an additional 914 shares in the last quarter. Finally, Truist Financial Corp boosted its holdings in shares of Ryan Specialty by 7.2% in the fourth quarter. Truist Financial Corp now owns 5,688 shares of the company’s stock valued at $365,000 after acquiring an additional 381 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Insider Buying and Selling

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Down 1.4%

RYAN stock opened at $68.14 on Wednesday. Ryan Specialty Holdings, Inc. has a 12 month low of $52.34 and a 12 month high of $77.16. The firm has a market cap of $17.85 billion, a PE ratio of 98.76, a P/E/G ratio of 1.19 and a beta of 0.68. The firm has a 50 day simple moving average of $70.11 and a 200 day simple moving average of $68.72. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts’ consensus estimates of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. During the same quarter last year, the business posted $0.35 EPS. The company’s revenue was up 25.0% on a year-over-year basis. Equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty’s dividend payout ratio is 141.18%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Royal Bank of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. TD Cowen assumed coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a “buy” rating and a $89.00 price objective for the company. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Barclays decreased their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a report on Friday, April 11th. Finally, The Goldman Sachs Group raised shares of Ryan Specialty from a “neutral” rating to a “buy” rating and increased their target price for the company from $74.00 to $81.00 in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $76.42.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.